Since our research showed that EVs derived from cancer cells had a high level of TA-MUC1 and were able to modulate a number of cholesterol metabolism proteins in normal HUVEC cells, we considered whether TA-MUC1, as a tumour cell-derived effector, also could impact the cholesterol metabolism of other types of cells within cocultured cellular environments. Here, MUC1 is linked to neoplasm.